Jul 13, 2018
Artificial Tendons and Ligaments Market Worth 35.0 Million USD by 2023
Jun 29, 2018
Arthrosurface receives FDA Clearance of Patellofemoral WaveKahuna Arthroplasty System
Jun 26, 2018
BioGend Therapeutics Completes Enrollment for The Pivotal Clinical Trial of One-Step Autologous Knee Cartilage Repair/Regeneration
Jun 19, 2018
Positive Knee Preservation Outcomes Using the Innovative Arthrosurface Inlay PF Wave(TM)
Jun 18, 2018
Arcuro Medical Receives FDA Regulatory Clearance
Jun 11, 2018
OrthoSensor, Inc. Secures Additional 510(K) Clearance
Apr 17, 2018
OrthoTrophix Will Present Data on Long-Term Clinical Benefit of TPX-100 in Mild to Severe Knee Osteoarthritis Patients at OARSI Annual Meeting 2018
Apr 16, 2018
Zimmer Biomet Announces FDA Clearance and First Surgical Case of the Persona® Trabecular Metal(TM) Tibia
Apr 13, 2018
Hip and Knee Replacement vs. Growth Factors & Stem Cell Therapy
Apr 03, 2018
Zamst Launches the ZK-X Knee Brace
Mar 26, 2018
Evidence for Delay of Total Knee Replacement (TKR) for Patients with Severe Osteoarthritis of the Knee Receiving Three Intra-articular (IA) Ampion(TM) Injections
Mar 20, 2018
Weight Loss After Stomach-Narrowing Surgery Eases Chronic Knee Pain
Mar 09, 2018
AmnioFix® Injectable Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the FDA for the Treatment of Osteoarthritis of the Knee
Mar 06, 2018
Smith & Nephew announces full commercial release of JOURNEY(TM) II XR Total Knee Arthroplasty
Mar 06, 2018
Return to play for soccer athletes and risk for future injury
Mar 05, 2018
Biorez Raises C-1 Financing and Prepares for Human Testing
Feb 05, 2018
New Data and Surgical Experiences with OMNIBotics® Active Spacer(TM) Ligament Balancing System Presented at Prestigious Orthopaedics Conference
Jan 16, 2018
medi USA introduces M.4s® PCL dynamic brace
Jan 16, 2018
Ampio Update of J.P. Morgan Meeting Events and Disease Modification Discussions
Dec 14, 2017
Ampio Pharmaceuticals Reports Positive Results for both Primary and Secondary Endpoints of Pivotal Phase 3 Trial of Ampion(TM) in Severe Osteoarthritis-of-the Knee (OAK)